Skip to main content

pyrazinamide

Generic: PYRAZINAMIDE·Brand: PYRAZINAMIDE

pyrazinamide: 4 clinical trials tracked.

pyrazinamide evidence translation

What we can confirm

4 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about pyrazinamide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (4)

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding

NCT07163143Registry updated 2025-09-09·Phase 3
Not yet recruiting

Primary endpoint: Proportion of participants with an unfavourable TB outcome

InterventionalRandomizedopen784 targetStarted 2025-11Completion 2029-044 sites · Pakistan, South Africa, ZimbabweUniversity College, London

Shortened Regimen for Drug-susceptible TB in Children

NCT06253715Registry updated 2026-07-24·Phase 3
Recruiting

Primary endpoint: TB disease-free survival at 48-weeks

InterventionalRandomizedopen860 targetStarted 2025-01Completion 2027-099 sites · India, Indonesia, Mozambique, South Africa…Johns Hopkins University

A Phase IIc, Open-Label, Randomized Controlled Trial of Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis (PRESCIENT)

NCT05556746Registry updated 2026-02-11·Phase 2
Active, not recruiting

Primary endpoint: Time to stable liquid culture conversion

InterventionalRandomizedopen156 targetStarted 2023-11Completion 2027-012 sites · Haiti, South AfricaBrigham and Women's Hospital

Multi-centric Prospective Cohort Study of TB Recurrence Free Cure Among Microbiologically Confirmed New Pulmonary Tuberculosis Patients Treated Under NTEP With the 4-month Moxifloxacin Containing Daily Regimen

NCT05047055Registry updated 2026-09-16
Completed

Primary endpoint: TB recurrence free cure

Observational550 enrolledStarted 2022-03Completion 2026-041 site · IndiaTuberculosis Research Centre, India